Fact sheet: AXA Framlington UK Mid Cap

Fund information

Fund name
AXA Framlington UK Mid Cap Z Acc
Fund company manager
AXA IM UK
Fund type
UKA
Fund manager
Dan Harlow
since 04/03/2011
Fund objective
The aim of this Fund is to provide long-term capital growth.
Benchmark
FTSE 250 (ex ITs) Index
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

16.71 %

1 Year rank in sector

231/273

Sector

UT UK All Companies

Yield

1.31

Fund size

£ 189.8 m

FE Risk score

91

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • UK
    96.29%
  • Money Market
    3.71%
  • Industrials
    40.66%
  • Consumer Services
    20.86%
  • Financials
    13.33%
  • Health Care
    7.32%
  • Consumer Goods
    4.84%
  • UK Equities
    96.29%
  • Money Market
    3.71%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-1.02 %10.64 %16.71 %42.7 %133.88 %
Sector-0.61 %9.29 %21.33 %24.63 %74.67 %
Rank within sector195 / 28081 / 278231 / 27321 / 2598 / 243
Quartile th3 rd2 nd4 th1 st1 st

Calendar performance

YTD-20172016201520142013
Fund9.49 %2.88 %19.9 %4.24 %42 %
Sector8.23 %11.16 %3.66 %0.59 %25.66 %
Rank within sector80 / 278245 / 27010 / 26244 / 25711 / 250
Quartile th2 nd4 th1 st1 st1 st

Risk statistics

Alpha3.92
Beta1.03
Sharpe0.77
Volatility11.52
Tracking error6.75
Information ratio0.57
R-Squared0.66

Price movement

52 week high250
52 week low183.8
Current bid price0
Current offer price0
Current mid price242.3

Holdings by region

  • 96.29% UK
  • 3.71% Money Market

Holdings by sector

  • 40.66% Industrials
  • 20.86% Consumer Services
  • 13.33% Financials
  • 7.32% Health Care
  • 4.84% Consumer Goods
  • 4.6% Technology
  • 3.71% Money Market
  • 3.28% Basic Materials
  • 1.4% Oil & Gas

Holdings by asset type

  • 96.29% UK Equities
  • 3.71% Money Market

Individual holdings

  • 2.7% RPC GROUP
  • 2.6% MELROSE INDUSTRIES PLC
  • 2.2% ASCENTIAL PLC
  • 2.1% PAYSAFE GROUP PLC
  • 2% GREENE KING
  • 2% ULTRA ELECTRONICS HLDGS
  • 1.9% BODYCOTE PLC
  • 1.9% CLINIGEN GROUP PLC
  • 1.9% DECHRA PHARMACEUTICALS
  • 1.9% TP ICAP PLC